|
Cell markers |
CD19 pan B cell | 7% | |
CD20 mature B cell | 7% | |
Kappa light chain | 3% | |
Lambda light chain | 3% | |
CD3 T cells | 69% | |
CD4 helper subset | 34% | |
CD8 cytotoxic subset | 32% | |
Flow comment | No evidence of lymphoproliferative disease | |
|
Immunologic markers |
Rheumatoid factor | <10 IU/mL | <15 |
Anti-CCP antibodies | 3 U/mL | <5 |
IgG | 8.7 g/L | 6.6–15.6 |
IgA | 1.73 g/L | 0.75–3.80 |
IM | 1.56 g/L | 0.40–3.10 |
IgE | 19 U/mL | <113 |
IgG1 | 3.76 g/L | 3.92–9.12 |
IgG2 | 2.60 g/L | 1.50–6.40 |
IgG3 | 0.48 g/L | 0.25–1.38 |
IgG4 | 0.27 g/L | 0.04–0.70 |
C1Q complement component | 155 mg/L | 118–244 |
C2 complement | 29.9 mg/L | 14.0–5.0 |
C3 complement | 1.30 g/L | 0.74–1.57 |
C4 complement | 0.28 g/L | 0.13–0.41 |
C5 complement | >200.0 mg/L | 100–169 |
C6 complement | 120 mg/L | 45–96 |
C7 complement | >110 mg/L | 55–85 |
C8 complement | 172.0 mg/L | 112–172 |
C9 complement | 500.0 mg/L | 125–265 |
Haptoglobin | 1.53 g/L | 0.30–2.15 |
A1 antitrypsin level | 2.38 g/L | 0.90–1.90 |
Serum total protein | 63 g/L | 46–70 |
Albumin EPG | 36 g/L | 37–51 |
Alpha1 globulin | 2.9 g/L | 0.9–2.0 |
Alpha2 globulin | 8.9 g/L | 2.8–7.7 |
Beta globulin | 8.9 g/L | 5.1–14.0 |
Gamma globulin | 6.9 g/L | 5.1–14.0 |
B2 microglobulin | 1.9 mg/L | 1.0–2.6 |
Glutamic acid decarboxylase antibody | <5 U/mL | ≤5 |
Islet cell antigen 512 antibodies | <8 U/mL | 0–15 |
Nuclear antibodies | Detected 1 : 640 speckled | |
dsDNA antibodies | Pattern | |
RNP antibodies | 7 IU/mL | 0–29 |
SM (Smith) antigen antibodies | Not detected | |
SSA/Ro 60 antibodies | Not detected | |
Ro-52/TRIM 21 antibodies | Not detected | |
SSB/La antibodies | Not detected | |
Scleroderma 70 antibodies | Not detected | |
Jo-1 antibodies | Not detected | |
Neuronal antibodies: Purkinje | Not detected | |
(Yo), PCA 2, ANNA-1, ANNA-2, Ma 1, Ma 2, amphiphysin, CV2, Tr, and SOX-1 | Not detected | |
Smooth muscle antibodies | Not detected <1 : 40 | |
Mitochondrial antibodies | Not detected <1 : 40 | |
Parietal cell antibodies | Not detected <1 : 40 | |
Intrinsic factor antibody | 4 U/mL | <20 |
Thyroglobulin antibodies | <20 IU/mL | 0–60 |
Thyroid peroxidase antibodies | <10 IU/mL | 0–35 |
Heat shock protein 70 antibodies | Detected A | |
Pancreatic islet cell antibodies | Not detected | |
Gliadin IgG deamidated antibodies | 2 units | <20 |
Transglutaminase IgA antibodies | <1 U/mL | <4 |
Neutrophil cytoplasm PR3 and MPO antibodies | Not detected | |
Ro-52, Mi-2, Ku, PM-Scl 100, PM-Scl 75, SRP, EJ, OJ, Jo-1, PL-7, and PL-12 | Negative | |
Zinc transporter 8 antibodies | Negative <10 U/mL | |
|
Genetic diagnostics |
Thiopurine methyltransferase genotype | No TMPT variant alleles | |
Factor V DNA | No factor V Leiden mutation | |
|